J&J Unit Loses Out To Medtronic In Stent Case

Law360, New York (March 23, 2006, 12:00 AM EST) -- In a big upset for Johnson & Johnson, an arbitration panel has ruled that a Medtronic Inc. coronary stent does not infringe on its rival’s patents, giving Medtronic the opportunity to take a large bite out of the $5 billion global stent market.

The independent panel found Wednesday that Medtronic’s Driver stent did not violate a 1997 settlement and cross-license agreement with patents of Johnson & Johnson’s Cordis unit.

The arbitration panel found its devices were licensed under the agreement between Medtronic and Cordis for the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.